In summary, our results demonstrate the primary role of Chop in the impaired activity CD8+ T cells in tumors and suggest the feasibility of overcoming tumor-induced CD8+ T cell suppression and increasing the efficacy of T cell-based immunotherapy by blocking Chop or ER stress. Here, DDIT3 is linked to neoplasm.